Cypherpunk Technologies Inc. (CYPH)

NCM – Цена в реальном времени. Валюта: USD

0.67

-0.01 (-1.82%)

Рынок открыт: Aug 12, 2026, 2:11 PM EDT

0.69

+0.01 (2.00%)

Предыдущая сессия: Aug 11, 2026, 7:59 PM EDT

12.08.2026

Cypherpunk Technologies Reports Second Quarter 2026 Financial Results

CAMBRIDGE, Mass., Aug. 12, 2026 /PRNewswire/ -- Cypherpunk Technologies Inc., (Nasdaq: CYPH) ("Cypherpunk"), today reported financial results for the second quarter ended June 30, 2026.

12.08.2026

Leap Therapeutics Announces Publication of DeFianCe Study Results in Clinical Cancer Research

Peer-reviewed analyses establish baseline plasma DKK1 as a continuous quantitative biomarker predicting deepening sirexatamab benefit in 2L mCRC patients In DKK1-high 2L mCRC patients, sirexatamab improved response, progression-free survival, and overall survival when added to bevacizumab and chemotherapy CAMBRIDGE, Mass., Aug. 12, 2026 /PRNewswire/ -- Leap Therapeutics, Inc., the biotechnology subsidiary of Cypherpunk Technologies Inc. (Nasdaq: CYPH), today announced the publication of results from the randomized Phase 2 DeFianCe study of sirexatamab (DKN-01), an anti-DKK1 monoclonal antibody, in Clinical Cancer Research.

Видео

No Data

There is no data to display

Пресс-релизы

12.08.2026

Cypherpunk Technologies Reports Second Quarter 2026 Financial Results

CAMBRIDGE, Mass., Aug. 12, 2026 /PRNewswire/ -- Cypherpunk Technologies Inc., (Nasdaq: CYPH) ("Cypherpunk"), today reported financial results for the second quarter ended June 30, 2026.

12.08.2026

Cypherpunk Technologies Inc. (CYPH)

Получите доступ ко всем премиум-функциям лучшего инструмента для анализа акций

Finranks

Компания

Контакты

Мы в соцсетях

Cypherpunk Technologies Inc. (CYPH)

Cypherpunk Technologies Reports Second Quarter 2026 Financial Results

Leap Therapeutics Announces Publication of DeFianCe Study Results in Clinical Cancer Research

Видео

No Data

Пресс-релизы

Cypherpunk Technologies Reports Second Quarter 2026 Financial Results

Leap Therapeutics Announces Publication of DeFianCe Study Results in Clinical Cancer Research

Cypherpunk Technologies Reports Second Quarter 2026 Financial Results

Leap Therapeutics Announces Publication of DeFianCe Study Results in Clinical Cancer Research

Видео

No Data

Пресс-релизы

Cypherpunk Technologies Reports Second Quarter 2026 Financial Results

Leap Therapeutics Announces Publication of DeFianCe Study Results in Clinical Cancer Research

Search stocks

Cypherpunk Technologies Inc. (CYPH)

Получите доступ ко всем премиум-функциям лучшего инструмента для анализа акций

Finranks

Компания

Контакты

Мы в соцсетях

Cypherpunk Technologies Inc. (CYPH)

Cypherpunk Technologies Reports Second Quarter 2026 Financial Results

Leap Therapeutics Announces Publication of DeFianCe Study Results in Clinical Cancer Research

Видео

No Data

Пресс-релизы

Cypherpunk Technologies Reports Second Quarter 2026 Financial Results

Leap Therapeutics Announces Publication of DeFianCe Study Results in Clinical Cancer Research

Cypherpunk Technologies Reports Second Quarter 2026 Financial Results

Leap Therapeutics Announces Publication of DeFianCe Study Results in Clinical Cancer Research

Видео

No Data

Пресс-релизы

Cypherpunk Technologies Reports Second Quarter 2026 Financial Results

Leap Therapeutics Announces Publication of DeFianCe Study Results in Clinical Cancer Research